Copyright: Panjin Tianyuan Pharmaceutical Co., Ltd. 
辽ICP备11017563号-1 
powered by  www.300.cn  jinzhou.300.cn
The largest silymarin production line in China has been established in Taibai
盘锦天源药业

The largest silymarin production line in China has been established in Taibai

Release time:
2018-06-20 17:12
abstract:
Recently,anannualproductionprojectof150tonssilymarininTaibaiCountyhaspassedtheacceptancetest.Expertsbelievethat"theproductionlinetechnologyisreasonable,theproductqualityisstable,theoveralltechnologyisintheleadinglevelinChina,andtheproductionscaleranksfirstinthecountry".TheplantingareaofmedicinalmaterialsinTaibaiCountyhasreachedmorethan80,000mu,and25%ofthepercapitanetincomeoffarmerscomesfromthetraditionalChinesemedicineindustry.ShaanxiSideCompanywasestablishedinTaibaiCountyasaprocessingenterpriseofChinesemedicinalmaterials.Itsself-developedsilymarinisaverypreciousChinesemedicinalmaterial.Lastyear,SideCompanyformallylaunchedasilymarinprocessingandproductionprojectwithatotalinvestmentof9.786millionyuan.TheprojectwascompletedandputintoproductioninOctoberofthatyear.Itcanproduceeightspecificationsofsilymarinproductswithanannualoutputof150tons,withanoutputvalueof39millionyuanandaprofitof5.23millionyuan.
American doctors have found that silymarin can treat mushroom poisoning
盘锦天源药业

American doctors have found that silymarin can treat mushroom poisoning

Release time:
2018-06-22 15:11
abstract:
DoctorsatGeorgetownUniversityHospitalintheUnitedStatesrecentlytriedamethodtotreatmushroompoisoning,usingsilymarin,adrugthathassuccessfullycuredallpoisonedpatients,accordingtotheUSFoodSafetyWebsite.Itisknownthatsilymarinisextractedfromtheplantsilymarin,whichcanpreventthetoxinproducedbypoisonousmushroomsfromreachingtheliverandcausingdamage.AmanitatoxinisproducedbyAmanitafungus,whichistheculpritof95%ofmushroompoisoningintheUnitedStates.Atpresent,thetreatmentofmushroompoisoningisnotperfect,becausetherearefewercasesofpoisoningintheUnitedStates,sodoctorsdonothavemuchchancetofindeffectivetreatmentofmushroompoisoning.
Silymarin exports from Panjin account for more than half of the country's total
盘锦天源药业

Silymarin exports from Panjin account for more than half of the country's total

Release time:
2018-06-22 15:09
abstract:
Theharvestseasonofsilymarinisapproaching.PanjinTianyuanPharmaceuticalCo.,Ltd.ismakinggreateffortstobuildanewworkshoptoexpandproductioncapacityandmeetordersfromallovertheworld.Afteryearsofdevelopment,PanjinCityhasformedauniquesilymarindeepprocessingindustrychain.Theannualproductioncapacityofsilymarinisnearly700tons,ofwhich300tonsareexported,accountingformorethan50%ofthetotalnationalexport.SilybumartichokehasbeenplantedinPanjinformanyyears,producingmorethan4000tonsofSilybumseedsannually.Atpresent,PanjinCityhas8silymarinprocessingenterprises,ofwhich2arecertifiedbyGMP.PanjinCityismakingfulluseoftheadvantagesofthelargestsilkwormprocessingbaseinChina,aimingatestablishingthewholeindustrialchainofsilkwormdeepprocessing,andstrengtheningthedevelopmentofnewproducts.Meanwhile,itisbuildingsilkwormdeepprocessingindustrialbasewithGaoshengEconomicZoneasthecarrier,throughjointventureswithWahaha,NongfuShanquanandotherlargeenterprisesathomeandabroad.Createtheleadingenterpriseofsilymarindeepprocessing.
Silymarin or diabetic nephropathy
盘锦天源药业

Silymarin or diabetic nephropathy

Release time:
2018-06-22 15:08
abstract:
ArecentstudybyFallahzadehetal.intheJournalofAmericanJournalofNephrologyfoundanewpotentialagentforthetreatmentofdiabeticnephropathy:silymarin.Diabeticnephropathyisthemostcommoncauseofdiabeticrenalfailureworldwide.Fallahzadehandhiscolleaguesstudiedanewpotentialagentfortreatingdiabeticnephropathy:theherbalsilymarin,whichhasantioxidantandanti-inflammatoryproperties.Researchersconductedarandomized,double-blind,placebo-controlledclinicaltrialtoassessthepotentialefficacyandsafetyofsilymarin,withtheexceptionoftype2diabetesmellituspatientstreatedwithRASinhibitorsandpatientswithobviousnephropathy.Patientswithsignificantproteinuriaandoliguriawererandomlyassignedtosilymarin.Intheensuingdiscussion,researchersfoundrareopportunitiesandspecialchallengesinusingplantproductstotreatdiseases.Comparedwithtraditionalmedicines,plantsareusuallyamixtureofunknowningredients,andspecialattentionmustbepaidtotheanalysisofallpotentialactiveingredientsandbatch-to-batchchanges.